Renaissance Gold Reports Fiscal Year 2014 Results
Sihuan Pharmaceutical Announces 2014 Interim Results
We expect higher growth at Ren Re down the road.
Our top managers could look beyond pharmaceuticals for additional yield.
Analysts say rosy assumptions are already baked into stock prices.
Plus, news on Cohen & Steers, Oppenheimer, and Putnam.